HomeAI · summaries
Storia in 4 fonti
Azioni Hims Hers: analisi tecnica e trimestrale Q2 2026
Azioni Hims Hers si consolidano sopra EMA20 e EMA50 ma sotto EMA200. Ricavi +40%, perdita netta e mercato in attesa del prossimo segnale chiave.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
markets.businessinsider.com
Hims & Hers Q2 Earnings Preview: Options Traders Brace for a 14.5% Move in HIMS Stock
Telehealth platform Hims & Hers Health (HIMS) will announce its second-quarter results on August 10. HIMS stock rose 6.5% to close at $31.59...
- ·
benzinga.com
Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earni
HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
